For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| General and administrative expenses | 1,195,687 | |||
| Loss from operations | -1,195,687 | |||
| Change in fair value of over-allotment liability | 0 | |||
| Interest earned on cash held in trust account | 8,484,511 | |||
| Total other income | 8,484,511 | |||
| Net income | 7,288,824 | |||
| Basic EPS | 0.3 | |||
| Diluted EPS | 0.3 | |||
| Basic Average Shares | 19,199,029 | |||
| Diluted Average Shares | 19,199,029 | |||
Oaktree Acquisition Corp. III Life Sciences (OACCU)
Oaktree Acquisition Corp. III Life Sciences (OACCU)